| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Schoenberg Mark is a Chief Medical Officer at UroGen Pharma Ltd.. Recent SEC Form 4 filings include 2 buys and 5 sells.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 349 | $27.51 | $9,601.97 | -1.9% | |
| Apr 27, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 70 | $24.35 | $1,704.50 | -0.4% | |
| Jan 27, 2020 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 322 | $29.15 | $9,386.30 | -3.4% | |
| Nov 19, 2019 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Buy | 1,960 | $28.17 | $55,213.20 | +32.6% | |
| Sep 4, 2019 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 343 | $33.92 | $11,634.56 | -5.4% | |
| Mar 21, 2019 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Buy | 272 | $37.01 | $10,066.45 | +6.3% | |
| Mar 6, 2019 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 1,991 | $37.30 | $74,264.30 | -31.5% |